Capex / revenue moved 272 bp lower
Capex / revenue changed -272 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed -272 basis points from the comparable as-filed period.
Cost of revenue changed -27.8% from the comparable as-filed period.
Current long-term debt changed +32.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -27.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -225 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +6.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating cash-flow margin changed -379 basis points from the comparable as-filed period.
Operating income changed -110.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Debt / revenue changed +4485 basis points from the comparable as-filed period.
Cash / debt changed -493 basis points from the comparable as-filed period.
Gross margin changed -45 basis points from the comparable as-filed period.
Selling, general & administrative changed -19.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -15.9% from the comparable as-filed period.
Receivables / revenue changed -538 basis points from the comparable as-filed period.
Working capital / assets changed +270 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed -5.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Total assets changed -6.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net debt changed +5.2% from the comparable as-filed period.
Shares outstanding changed +1.0% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Reported total debt changed -2.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross debt changed -2.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -106 basis points from the comparable as-filed period.
Debt / assets changed +134 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed -106.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed -9.6% from the comparable as-filed period.
SBC / revenue changed +8 basis points from the comparable as-filed period.
Working capital changed +1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +1 basis points from the comparable as-filed period.
Debt / revenue changed -492 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +497 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +453 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +54 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +24.4% from the comparable as-filed period.
Gross margin changed +42 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +26.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +6.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +5.2% from the comparable as-filed period.
Working capital / assets changed -171 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +8.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +1.0% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Capex / revenue changed +44 basis points from the comparable as-filed period.
Cash & equivalents changed -2.6% from the comparable as-filed period.
Cash / debt changed -118 basis points from the comparable as-filed period.
Net debt changed +2.9% from the comparable as-filed period.
Stock-based compensation changed -13.0% from the comparable as-filed period.
Current assets changed +1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed -1.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Debt / assets changed +98 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross debt changed +1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Reported total debt changed +1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Receivables / revenue changed +93 basis points from the comparable as-filed period.
SBC / revenue changed -5 basis points from the comparable as-filed period.
Cost of revenue changed +4.7% from the comparable as-filed period.
R&D / revenue changed +17 basis points from the comparable as-filed period.
Selling, general & administrative changed +0.7% from the comparable as-filed period.
Inventory changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.